Bacillus Calmette-Guerin clinical trials

A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer

This study looked at a new medicine called sasanlimab for early-stage bladder cancer that hasn't spread. It compared sasanlimab with or without BCG, a common bladder cancer treatment. The goal was to see how safe and effective sasanlimab is in preventing the cancer from coming back.